Every Form 4 that Iridex Corp (IRIX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow IRIX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full IRIX filings page.
IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased 7,900 shares of common stock on September 16, 2026 in an open market or private transaction at $0.63 per share. Following this purchase, he directly holds 185,306 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported.
IRIDEX CORP (IRIX) reported that its Chief Financial Officer, Romeo R. Dizon, purchased 2,354 shares of common stock on September 14, 2026 at $0.65 per share in an open-market or private transaction. Following this buy, he directly holds 177,406 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported for this transaction.
IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased 5,100 shares of common stock on September 10, 2026 at $0.68 per share in an open-market or private transaction. Following this purchase, he directly holds 175,052 shares of IRIDEX common stock. No Rule 10b5-1 trading plan is reported for this transaction.
IRIDEX CORP (IRIX) reported that Chief Financial Officer Romeo R. Dizon purchased shares of the company’s Common Stock. On 2026-08-24, he bought 1,300 shares at $0.7488 per share and 5,368 shares at $0.7499 per share in open-market or private transactions. Following these purchases, his reported direct ownership increased to 169,952 Common Stock shares.
Mercer Patrick reported acquisition or exercise transactions in this Form 4 filing.
IRIDEX CORP President and CEO Patrick Mercer received equity awards on July 10, 2026, including 100,000 restricted stock units, 100,000 performance RSUs that vest if the share price reaches $2.50 for 30 consecutive trading days, and options for 200,000 shares at $1.10 per share. The RSUs and options vest as to one-third of the shares on July 10, 2027 and on each one-year anniversary thereafter, subject to continued service. Following these awards he directly holds 468,784 common shares, plus 100,000 performance units and 200,000 options.
IRIDEX CORP awarded its Chief Financial Officer, Romeo R. Dizon, equity-based compensation consisting of 30,000 restricted stock units (RSUs) and a stock option for 170,000 shares. Each RSU represents a contingent right to receive one share of common stock, vesting in three equal annual installments: one-third on July 10, 2027 and one-third on each of the next two anniversaries, subject to his continued service.
The option gives Dizon the right to purchase up to 170,000 shares of IRIDEX common stock at an exercise price of $1.10 per share and expires on July 10, 2033. Following these awards, he holds 163,284 shares of common stock directly, in addition to the newly granted stock option. These are compensation grants rather than open‑market purchases or sales.
IRIDEX CORP disclosed a non-cash equity transaction with a major shareholder. Novel Inspiration International Co., Ltd., a 10% owner, received 111,997 shares of common stock as a quarterly interest payment on a Convertible Promissory Note issued on March 19, 2025. After this issuance, Novel Inspiration directly beneficially owns 551,429 shares, which are also indirectly beneficially owned by Shih-Yao David Lin as the sole officer, director and stockholder of Novel Inspiration.
IRIDEX CORP Chief Financial Officer Romeo R. Dizon reported a tax-related share withholding. On this Form 4, 2,691 shares of Common Stock were disposed of at $1.12 per share to satisfy a tax obligation, classified as a tax-withholding disposition rather than an open-market sale. After this transaction, he directly holds 133,284 shares of IRIDEX CORP Common Stock.
IRIDEX CORP President and CEO Patrick Mercer reported a tax-withholding disposition of 3,990 shares of Common Stock at $1.12 per share. This transaction satisfied tax obligations by delivering shares rather than through an open-market sale. After the transaction, he directly holds 368,784 shares.
IRIDEX CORP Chief Financial Officer buys additional shares on the open market. On this Form 4, Romeo R. Dizon reported purchasing 975 shares of IRIDEX common stock in an open-market transaction at an average price of $1.1386 per share. Following this buy, he directly owns 135,975 common shares.
IRIDEX CORP’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On June 11, 2026, he bought 1,675 shares of IRIDEX common stock at $1.14 per share. Following this transaction, he directly owns 135,000 common shares, indicating a modest increase to his existing position.
IRIDEX CORP’s Chief Financial Officer Romeo R. Dizon reported an open-market purchase of 2,400 shares of common stock at about $1.12 per share. After this transaction, he directly holds 133,325 shares. This is a relatively small, routine insider buy that modestly increases his direct ownership.
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, bought additional company stock in the open market. He purchased 2,521 shares of Common Stock at a price of $1.15 per share. Following this transaction, he directly holds 130,925 shares, increasing his personal stake in the company.
IRIDEX CORP Chief Financial Officer Romeo R. Dizon bought additional company stock in the open market. He purchased 2,400 shares of common stock at a price of $1.17 per share. After this transaction, he directly owns a total of 128,404 IRIDEX common shares.
IRIDEX CORP President and CEO Patrick Mercer reported a tax-related share disposition on Common Stock. On this Form 4, 19,233 shares were delivered at $1.01 per share to cover tax obligations, and he now directly holds 372,774 shares of Common Stock.
IRIDEX Corp Chief Financial Officer Romeo R. Dizon reported an open-market purchase of 5,004 shares of common stock at $1.00 per share. Following this transaction, he directly holds 126,004 shares of IRIDEX common stock, modestly increasing his personal stake in the company.
IRIDEX CORP reported that major shareholder Novel Inspiration International Co., Ltd. received 87,949 shares of Common Stock on April 1, 2026. These shares were issued as a quarterly interest payment on a Convertible Promissory Note dated March 19, 2025.
After this stock-for-interest transaction, Novel Inspiration holds a total of 439,432 IRIDEX common shares directly. The Form 4 is filed jointly with Shih-Yao David Lin, who is the sole officer, director and stockholder of Novel Inspiration, but the shares are owned by the company, not by Lin personally.
IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On March 6, 2026, he bought 1,110 shares of IRIDEX common stock at $1.26 per share. Following this transaction, his direct holdings increased to 121,000 shares.
Dizon Romeo R reported open-market purchase transactions in a Form 4 filing for IRIX. The filing lists transactions totaling 2,200 shares at a weighted average price of $1.34 per share. Following the reported transactions, holdings were 119,890 shares.
IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, bought company stock in the open market. On 02/12/2026, he purchased 1,500 shares of IRIDEX common stock at a price of $1.43 per share in a direct transaction.
Following this purchase, Dizon directly beneficially owned 117,690 shares of IRIDEX common stock. The filing records this as an open-market purchase under the standard insider transaction reporting rules.
IRIDEX Corp’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of common stock. On 02/10/2026, he acquired 1,000 shares of IRIDEX common stock at a price of $1.46 per share.
Following this transaction, Dizon directly beneficially owned a total of 116,190 shares of IRIDEX common stock. The filing indicates the ownership is held directly, and the Form 4 was signed on his behalf by attorney-in-fact Nilo De Castro.
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, reported a stock purchase in a Form 4 filing. On 02/03/2026, he acquired 2,500 shares of IRIDEX common stock at a price of $1.38 per share. Following this transaction, he directly owns 115,190 common shares.
IRIDEX Corporation’s Chief Financial Officer, Romeo R. Dizon, reported buying additional company stock. On January 29, 2026, he purchased 1,101 shares of common stock at $1.442 per share, bringing his directly held stake to 112,690 shares.
IRIDEX Corporation’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On January 28, 2026, he bought 1,300 shares of common stock at $1.46 per share. Following this transaction, he directly owns 111,589 shares of IRIDEX common stock.
IRIDEX Corporation’s Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On 01/27/2026, he bought 3,385 shares of Common Stock at a price of $1.4799 per share, as shown by transaction code "P" for a purchase. Following this transaction, he beneficially owns 110,289 shares of IRIDEX Common Stock in direct ownership.
IRIDEX Corp Chief Financial Officer buys additional shares. On 01/26/2026, CFO Romeo R. Dizon purchased 1,243 shares of IRIDEX common stock at $1.52 per share in an open-market transaction coded "P" (purchase). After this trade, he directly owned 106,904 shares of IRIDEX common stock. This filing reflects a change in his personal share ownership and does not describe any change in the company’s operations or financial results.
IRIDEX Corporation’s Chief Financial Officer, Romeo R. Dizon, purchased additional shares of the company’s common stock. On 01/23/2026, he bought 5,221 shares at a weighted average price of $1.4779 per share, with individual trade prices ranging from $1.475 to $1.48. Following this purchase, he beneficially owns 105,661 shares of IRIDEX common stock in direct ownership. The transaction was reported as an open-market or private purchase, with full trade-level pricing details available upon request from the company, its security holders, or the SEC staff.
IRIDEX CORP Chief Financial Officer Romeo R. Dizon reported open-market purchases of the company’s common stock. On January 20, 2026, he bought 2,100 shares at a price of $1.4987 per share. On January 21, 2026, he made two additional purchases of 409 shares at $1.53 per share and 1,750 shares at $1.49 per share.
After these transactions, Dizon directly owned 100,440 shares of IRIDEX common stock. The filing indicates these holdings are reported as directly owned, with no indirect ownership relationships noted.
Iridex Corp’s chief financial officer, Romeo R. Dizon, reported multiple acquisitions of the company’s common stock. On January 16, 2026, he acquired several small lots of shares at prices ranging from $1.38 to $1.45 per share, each coded as an acquisition transaction.
After these trades, his directly held beneficial ownership in Iridex common stock was reported at 96,181 shares. All reported holdings are shown as directly owned in his name.
IRIDEX Corporation reported an insider share issuance involving a major holder. On 01/02/2026, Novel Inspiration International Co., Ltd., a 10% owner, received 116,540 shares of IRIDEX common stock at a stated price of $0 per share as reflected in the Form 4.
The filing explains that these shares were issued as a quarterly interest payment on a Convertible Promissory Note dated March 19, 2025 between IRIDEX and Novel Inspiration. After this transaction, Novel Inspiration is shown as beneficially owning 351,483 shares of IRIDEX common stock. The Form 4 is filed jointly by Novel Inspiration and Shih‑Yao David Lin, who is the sole officer, director and stockholder of Novel Inspiration, while the shares are owned directly by Novel Inspiration.
IRIDEX CORP’s 10% owner Novel Inspiration International Co., Ltd. reported receiving additional common shares. On 10/01/2025, Novel Inspiration acquired 97,610 shares of IRIDEX common stock at a reported price of $0.0000 per share, increasing its beneficial ownership to 234,943 shares held directly.
The shares were issued as a quarterly interest payment on a Convertible Promissory Note that IRIDEX had issued to Novel Inspiration on March 19, 2025. The Form 4 is filed jointly by Novel Inspiration and Shih-Yao David Lin, who is the sole officer, director and stockholder of Novel Inspiration, while the shares themselves are owned directly by Novel Inspiration.
IRIDEX Corp reported an insider ownership change involving a major shareholder. On July 1, 2025, Novel Inspiration International Co., Ltd., identified as a 10% owner of IRIDEX (IRIX), was issued 137,333 shares of common stock.
The Form 4 states that these shares were issued as a quarterly interest payment on a Convertible Promissory Note dated March 19, 2025 between IRIDEX and Novel Inspiration. The shares were received at a stated price of $0.00 per share, and the filing shows 137,333 shares beneficially owned following the transaction, held directly by Novel Inspiration.
The report is filed jointly by Novel Inspiration and Shih-Yao David Lin, who is described as the sole officer, director and stockholder of Novel Inspiration, linking his interests to this 10% ownership position.
IRIDEX Corporation director reports open-market stock purchase
A director of IRIDEX Corporation reported buying 2,000 shares of common stock on 12/16/2025 at a price of $1.0099 per share. After this transaction, the director beneficially owns 251,550 shares directly and 69,300 shares indirectly through a spouse. An additional 81,150 shares are held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust, which hold the shares as tenants in common under trust agreements dated August 16, 2016 and August 17, 2016, respectively.
IRIDEX director William M. Moore reported buying 20,000 shares of IRIDEX common stock on 12/15/2025, shown as a purchase transaction.
The shares were acquired in multiple trades at weighted average prices between $0.98 and $0.9885 per share. Following this transaction, Moore directly owned 249,550 IRIDEX shares, with an additional 69,300 shares held indirectly by his spouse and 81,150 shares held indirectly through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.
Iridex Corp director reported buying additional company common stock in December 2025. On December 11, 2025, the director purchased 9,080 shares at a weighted average price between $0.9508 and $0.97. On December 12, 2025, the director purchased a further 20,920 shares at a weighted average price between $0.9205 and $0.97, bringing direct beneficial ownership to 280,674 shares of Iridex common stock.
The report also discloses indirect holdings of 69,300 shares held by the director’s spouse and 30,026 shares held through the William M. Moore Trust and the Patricia A. Moore Trust as tenants in common.
IRIDEX Corp's chief financial officer, Romeo R. Dizon, reported acquiring 2,365 shares of common stock on 12/12/2025 at $0.9709 per share. Following this purchase, his direct ownership increased to 92,685 IRIDEX common shares, as disclosed in the Form 4 insider transaction report.
IRIDEX CORP reported that its Chief Financial Officer, Romeo R. Dizon, bought additional company stock. On 11/20/2025, he acquired 5,760 shares of common stock in an open market purchase at a price of $0.96 per share. After this transaction, he beneficially owned 88,736 shares of IRIDEX common stock directly.
IRIDEX Corporation (IRIX) reported an insider share purchase by its Chief Financial Officer, Romeo R. Dizon. On 11/19/2025, the CFO bought 1,000 shares of common stock at $0.96 per share in an open-market purchase, bringing his directly owned holdings to 82,976 shares. This activity was reported on a Form 4 filed for a single reporting person.
IRIDEX Corp's Chief Financial Officer, Romeo R. Dizon, reported an open-market purchase of company stock. On 11/18/2025, he bought 2,133 shares of IRIDEX common stock at a price of $0.94 per share, as shown in Table I of the filing. After this transaction, he beneficially owned 81,976 shares of IRIDEX common stock in direct ownership. This report was filed as a Form 4 by a single reporting person, indicating a change in his personal holdings of IRIDEX equity.
IRIDEX Corporation (IRIX) director share purchases disclosed. A company director reported open-market purchases of common stock in two transactions. On 11/14/2025, the director bought 28,157 shares at a weighted average price of $0.9676 per share, in multiple trades between $0.9367 and $0.98. On 11/17/2025, the director bought 21,843 shares at a weighted average price of $0.9654 per share, in multiple trades between $0.95 and $0.98.
After these transactions, the director beneficially owns 250,674 shares directly. In addition, 69,300 shares are held indirectly by the director’s spouse, and 30,026 shares are held indirectly through trusts identified in the footnotes. The filing notes that detailed trade‑by‑trade pricing information is available upon request.
IRIDEX CORP (IRIX) reported an insider stock purchase by its Chief Financial Officer, Romeo R. Dizon. On 11/17/2025, the reporting person bought 3,034 shares of common stock at a price of $0.96 per share and an additional 90 shares at $0.9569 per share in open-market transactions coded as purchases ("P").
Following these transactions, the reporting person beneficially owns 79,843 shares of IRIDEX common stock, held directly. The filing indicates that it is made by one reporting person and confirms the officer status as Chief Financial Officer.
IRIDEX Corporation reported an insider share purchase by its Chief Financial Officer. On 11/14/2025, the CFO acquired 14,769 shares of common stock in an open market purchase coded "P" at a price of $0.88 per share. Following this transaction, the officer beneficially owned 76,719 shares of IRIDEX common stock held directly. This type of report provides transparency about trading activity by senior management in the company’s equity.